Dr Reddys Laboratories (RDY) Retained Earnings (2009 - 2026)

Dr Reddys Laboratories has reported Retained Earnings for 14 years, with the latest figure at $3.8 billion in Q2 2026.

• On a quarterly basis, Retained Earnings fell 2.36% year-over-year to $3.8 billion in Q2 2026; TTM through Jun 2026 was $3.8 billion, a 2.36% decrease from a year earlier, with the FY2026 full-year figure at $3.8 billion, up 1.46% from the prior year.
• Retained Earnings was $3.8 billion for Q2 2026 at Dr Reddys Laboratories, down from $3.9 billion in the prior quarter.
• The five-year high for Retained Earnings was $3.9 billion in Q4 2025, with the low at $2.3 billion in Q1 2022.
• Average Retained Earnings over 5 years is $3.2 billion, with a median of $3.3 billion recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Retained Earnings rose 21.79% in 2024, then fell 2.36% in 2026.
• Over 5 years, Retained Earnings stood at $2.5 billion in 2022, then increased by 20.24% to $3.0 billion in 2023, then climbed by 17.11% to $3.5 billion in 2024, then advanced by 10.79% to $3.9 billion in 2025, then slipped by 4.15% to $3.8 billion in 2026.
• The last three Retained Earnings figures came in at $3.8 billion (Q2 2026), $3.9 billion (Q1 2026), and $3.9 billion (Q4 2025), per Business Quant data.